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OBJECTIVE — We examined maximal graded exercise test (GXT) results in 5,783 over-
weight/obese men and women, aged 45–76 years, with type 2 diabetes, who were entering the
Look AHEAD (Action for Health in Diabetes) study, to determine the prevalence and correlates
of exercise-induced cardiac abnormalities.
RESEARCH DESIGN AND METHODS — Participants underwent symptom-limited
maximal GXTs. Questionnaires and physical examinations were used to determine demo-
graphic, anthropometric, metabolic, and health status predictors of abnormal GXT results,
which were deﬁned as an ST segment depression 1.0 mm, ventricular arrhythmia, angina
pectoris, poor postexercise heart rate recovery (22 bpm reduction 2 min after exercise), or
maximal exercise capacity less than 5.0 METs. Systolic blood pressure response to exercise was
examined as a continuous variable, without a threshold to deﬁne abnormality.
RESULTS — Exercise-induced abnormalities were present in 1,303 (22.5%) participants, of
which 693 (12.0%) consisted of impaired exercise capacity. ST segment depression occurred in
440(7.6%),abnormalheartraterecoveryin206(5.0%),anginain63(1.1%),andarrhythmiain
41 (0.7%). Of potential predictors, only greater age was associated with increased prevalence of
allabnormalities.Otherpredictorswereassociatedwithsome,butnotall,abnormalities.Systolic
blood pressure response decreased with greater age, duration of diabetes, and history of cardio-
vascular disease.
CONCLUSIONS — We found a high rate of abnormal GXT results despite careful screening
for cardiovascular disease symptoms. In this cohort of overweight and obese individuals with
type 2 diabetes, greater age most consistently predicted abnormal GXT. Long-term follow-up of
these participants will show whether these abnormalities are clinically signiﬁcant.
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C
ardiovascular disease (CVD) risk
factors improve with exercise in in-
dividuals with diabetes (1). Simi-
larly, individuals with diabetes who are
physically active or have higher ﬁtness
levels have reduced CVD incidence and
mortality (2,3). Nevertheless, participa-
tion in exercise may involve risks for in-
dividuals with diabetes because of their
high prevalence of CVD, including silent
ischemia, and other comorbid conditions
(4).
Knowledge about the typical cardio-
vascular responses to exercise in individ-
ualswithtype2diabeteshascomemainly
from small clinic-based studies (5) and a
few larger studies in the general popula-
tion (4,6,7). The Look AHEAD (Action
for Health in Diabetes) study is a multi-
center randomized clinical trial designed
to evaluate the long-term effects of an in-
tensive lifestyle intervention program of
weight loss and physical activity on mor-
bidity and mortality from CVD in over-
weight and obese individuals with type 2
diabetes(8).Gradedexercisetests(GXTs)
with electrocardiographic monitoring
were conducted at baseline in 5,783 indi-
viduals, providing the largest sample of
systematic stress testing ever conducted
in individuals with type 2 diabetes. The
aims of this analysis are to examine the
range of abnormal exercise responses and
to examine the degree to which demo-
graphic factors, health characteristics,
and medication use associate with ab-
normal exercise responses. Identifying
predictors from readily available demo-
graphic and clinical data may assist risk
stratiﬁcation before exercise testing or
exercise prescription for individuals
with diabetes.
RESEARCH DESIGN AND
METHODS— This was a cross-sectional
analysis of GXTs among individuals
screened for participation in the Look
AHEAD clinical trial (8). Individuals with
previously diagnosed diabetes, aged
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2 (27
kg/m
2 if using insulin) were recruited. In-
formed consent was obtained from all
participants before screening, consistent
with the Declaration of Helsinki and each
center’s institutional review board guide-
lines. Participants were excluded if they
had baseline A1C 11%, resting blood
pressure 160/100 mmHg, fasting trig-
lycerides 600 mg/dl, or factors that
might limit their successful participation
in an intensive lifestyle intervention fo-
cused on weight loss.
Eligibility was determined by a series
of clinical visits (Fig. 1). Individuals with
a history of recent or signiﬁcant cardio-
vascular disease or symptoms (deﬁned in
ref. 8) were excluded before exercise test-
ing. Eligible participants underwent a
maximal GXT within 3 months of the ini-
tial examination.
Immediately before the GXT, a brief
physical examination was conducted to
assess contraindications to exercise
which, if present, disqualiﬁed volunteers
from further participation. The use of
-blockers was not a study exclusion
criterion. However, because heart rate
data from participants using -blockers
were not considered informative, these
heart rate data are not included in this
report. Other data from participants
taking -blockers (e.g., ST segment
changes) are included. All GXTs were
done before randomization, and the
analyses herein include the 5,783 indi-
viduals who underwent the GXT, re-
gardless of whether they were ultimately
randomized.
Demographic and health status
predictors
Full details of the Look AHEAD design and
methods (8) and participants (9) are re-
ported elsewhere. Height and weight were
measured using standard protocols and
were used to calculate BMI (weight in kilo-
grams divided by the square of height in
meters). Seated heart rate and blood pres-
sure measurements were obtained after a
5-min rest using an automated Dinamap
Monitor Pro 100. Two measurements were
obtained and averaged.
GXT
TheGXTprotocolwasdesignedsuchthat
mostparticipantswouldachievemaximal
voluntary exertion over 8–12 min, in
accordance with American College of
Sports Medicine recommendations (10).
A supine resting 12-lead electrocardio-
gram (ECG) was ﬁrst obtained. Each par-
ticipant started walking on the treadmill
at 1.5 mph on a level (0%) grade, and
speedwasincreasedgraduallyby0.5mph
units until the participant reached a brisk
but comfortable self-selected walking
speed or 4.0 mph. This self-selected
treadmill speed was used for the GXT.
After a brief rest, the GXT was initi-
ated at 0% grade. The speed remained
constantwhilethegradewasincreasedby
1% every minute until voluntary exhaus-
tion or until the participant exhibited or
reported signs or symptoms of exercise
intolerance, using American College of
Sports Medicine criteria (10). During the
last 10 s of each exercise stage and at the
point of test termination, heart rate was
measuredfroma12-leadECG,andrating
of perceived exertion (RPE) was obtained
usingtheBorg15-categoryscale(10).Un-
der this RPE scale, the participant reports
exertion levels along a scale from 6 (no
exertion) to 20 (maximal exertion).
Blood pressure was measured during
the last 45 s of each even minute exercise
stage (i.e., stages 2, 4, and 6) and at the
point of test termination. Peak exercise
capacity expressed as METs was esti-
mated from treadmill speed and elevation
(10). At test termination, the participant
wasplacedinasupinepositionwithheart
rate and blood pressure monitored at
2-min intervals for at least 8 min or until
the supervising physician indicated that
sufﬁcient recovery had occurred. The su-
pervising physician was asked to record
any signiﬁcant ST segment changes, type
and frequency of arrhythmias, ECG-
determinedheartrate,andbloodpressure
at rest and at speciﬁed times during each
test.
Deﬁnition of abnormal exercise tests
Abnormal GXT results were deﬁned by
criteria related to risk of acute exercise-
related cardiovascular events or CVD
mortality: electrocardiographic changes
suggestive of coronary ischemia (ST seg-
ment depression of 1.0 mm) or ventric-
ular arrhythmias (ventricular ﬁbrillation,
ventricular tachycardia, runs of at least
three premature ventricular contractions,
or exercise-induced bundle branch
block), exercise-induced angina, abnor-
mal hemodynamic response (heart rate
recovery 22 bpm over 2 min after exer-
cise [11,12]), and impaired exercise ca-
pacity (highest achieved workload of 5
METs [3,7]). Because of the lack of a con-
sensus threshold for deﬁning an abnor-
mal systolic blood pressure (SBP)
Figure1—Studyentryﬂowdiagram.Participantsincludedinthepresentanalysiswerethe5,783
individuals seen in screening visit 3.
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ous variable.
Statistical analysis
Logistic regression was used to assess re-
lationships between the prevalence of
each abnormality and individual risk fac-
tors.TherelationshipsbetweenmeanSBP
during exercise and risk factors were as-
sessed with ANOVA.
RESULTS— Look AHEAD screened
27,260 potential participants, of whom
5,783 underwent a GXT (Fig. 1) and are
described in Table 1. Their mean
achieved RPE was 19.3, and the 25th per-
centile was 19, according to the Borg
scale, which indicates that most partici-
pants reported being at or very near max-
imal voluntary effort. Overall, 1,303
(22.5%)testswereabnormal(Fig.2),and
638 subjects were not randomly assigned
into the Look AHEAD trial because of
safety concerns due to GXT abnormali-
ties. The most frequent abnormality was
impaired exercise capacity (12.0%), fol-
lowed by ST segment depression (7.6%),
heart rate recovery abnormalities (5.0%),
exercise-inducedangina(1.1%),andven-
tricular arrhythmias (0.7%).
Thebivariateassociationsbetweeneach
category of abnormality and predictor vari-
ables are shown in Fig. 2 and supplemen-
tary Table A1 (available in an online
appendix at http://care.diabetesjournals.
org/cgi/content/full/dc09-1787/DC1). Age
is the only signiﬁcant predictor of all types
of abnormal response. A1C was not associ-
ated with any GXT abnormalities.
GreatermeanSBPresponseswereob-
served for participants who were male,
younger, non-Latino, or African Ameri-
can;didnotuseantihypertensivemedica-
tionsorinsulin;andhadmidrangeresting
SBPorhigherrestingdiastolicbloodpres-
sure (DBP), shorter duration of diabetes,
no history of CVD, or BMI 40 kg/m
2
(Table 2).
Higherworkloadwasattainedbypar-
ticipants who were male, younger, or
Latino; were not taking blood pressure
medications; had lower baseline SBP,
higher baseline DBP, shorter durations of
diabetes, no history of CVD, or lower
BMI; or did not use insulin (Table 2).
CONCLUSIONS — Morethanonein
ﬁve (22.5%) Look AHEAD participants
had an abnormal GXT despite a pre-
screening process that excluded anyone
who reported CVD symptoms during the
previous 3 months or those with any his-
Table 1—Characteristics of cohort receiving baseline GXT
Frequency
Sex and age
Female 3,441 (59.5)
45–54 years 903 (26.2)
55–64 years 1,907 (55.4)
65–76 years 631 (18.3)
Male 2,342 (40.5)
45–54 years 404 (17.2)
55–64 years 1,301 (55.6)
65–76 years 637 (27.2)
Race and ethnicity*
Latino 731 (12.6)
African American 6 (0.8)
American Indian 2 (0.3)
White 214 (29.3)
Other/multiracial/unknown 509 (69.6)
Not Latino 4,994 (86.4)
African American 914 (18.3)
American Indian 308 (6.2)
White 3,569 (71.5)
Other/multiracial/unknown 203 (4.1)
BMI (kg/m
2)†
25 to 30 821 (14.2)
30 to 35 2,008 (34.8)
35 to 40 1,618 (28.1)
40 1,319 (22.9)
A1C (%)‡
7.0 3,118 (54.1)
7.0–8.9 2,133 (37.0)
9.0–10.9 513 (8.9)
Insulin use
No 4,839 (83.7)
Yes 944 (16.3)
Time with diabetes (years)§
5 2,545 (44.4)
5t o10 1,558 (27.2)
10 1,634 (28.5)
CVD history
No 5,013 (86.7)
Yes 770 (13.3)
SBP (mmHg)
120 1,632 (28.2)
120 to 130 1,198 (20.7)
130 to 140 1,264 (21.9)
140 to 150 1,026 (17.7)
150 to 160 663 (11.5)
DBP (mmHg)
70 2,762 (47.8)
70–84 2,618 (45.3)
85 403 (7.0)
Use of blood pressure medication
No 1,969 (34.0)
Yes 3,814 (66.0)
Randomized
No 638 (11.0)
Yes 5,145 (89.0)
Data are n (%). *Ethnicity is missing for 58 participants because of a change in how it was recorded. †BMI
ismissingfor17participants.‡MeanSDA1Cis7.101.32%(missingfrom17participants).§Self-report
(missing from one participant). Self-report of prior heart attack, stroke, transient ischemia attack, bypass
surgery, angioplasty, endarterectomy, congestive heart failure, or stent.
Curtis and Associates
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studies have sought to determine the
prevalence of CVD in individuals with di-
abetes,usingvariousmarkersforCVD.In
the Milan Study on Atherosclerosis in Di-
abetes (MiSAD) (4,5), all participants had
diabetes and were aged 40–65 years at
studyentry,andonlySTsegmentchanges
constituted an abnormal GXT. In MiSAD,
Figure2—Numberorprevalence(%)ofabnormaltestprevalencebypredictorvariables.A:Numberofabnormaltests.B:Abnormaltestprevalence
(%) by sex: f, men;  , women. C: Abnormal test prevalence (%) by age: f, 45–54 years; , 55–64 years;  , 65–75 years. D: Abnormal test
prevalence(%)byethnicity:f,Latino; ,notLatino.E:Abnormaltestprevalence(%)byrace:f,AfricanAmerican; ,AmericanIndian; ,white;
p, other/multiracial/unknown. F: Abnormal test prevalence (%) by use of blood pressure medicines: f, yes;  , no. G: Abnormal test prevalence (%)
by systolic blood pressure: f, 120 mmHg; , 120–129 mmHg;  , 130–139 mmHg; p, 140–149 mmHg; , 150–159 mmHg. H: Abnormal test
prevalence (%) by diastolic blood pressure: f, 70 mmHg; , 70–84 mmHg;  , at least 85 mmHg. I: Abnormal test prevalence (%) by years with
diabetes: f, 5 years; ,5t o10 years;  , at least 10 years. J: Abnormal test prevalence (%) by cardiovascular disease history: f, yes;  , no.
K: Abnormal test prevalence (%) by BMI: f,2 5t o30 kg/m
2; ,3 0t o35 kg/m
2;  ,3 5t o40 kg/m
2; p, at least 40 kg/m
2. L: Abnormal test
prevalence (%) by use of insulin: f, yes;  , no. *P  0.05. Ang, Exercise-induced angina; Arr, ventricular arrhythmia (ventricular ﬁbrillation,
ventricular tachycardia, runs of at least three premature ventricular beats, or exercise-induced bundle branch block); Any, any abnormality from
among those listed; Ex C, impaired exercise capacity (highest achieved workload of 5.0 METs; HRR, heart rate recovery of 22 bpm over 2 min
after exercise; ST, ST segment depression of at least 1.0 mm.
Abnormal stress tests in adults with diabetes
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mal tests. Although this overall abnormal
rate is lower than what we observed,
MiSAD had a higher rate of ST segment
changes than our population did (7.6%).
The Detection of Ischemia in Asymptom-
atic Diabetics (DIAD) (13) study, which
evaluated 522 individuals with type 2 di-
abetes, who were aged 50–75 years and
had no history of CVD, found that 113
(22%)hadabnormaladenosineperfusion
stresstests.Totheextentthatthesemark-
ersapproximatetrueCVD,theprevalence
of CVD in middle-aged asymptomatic di-
abetic adults is likely between 13 and
22%.Ouroverallratesareconsistentwith
this observation.
Age was the only predictor that
showed a consistent association with ab-
normal tests. Although this is the ﬁrst de-
scription of such a large group of diabetic
participants to undergo stress testing, in
nondiabetic populations, the association
ofgreateragewithGXTabnormalitieshas
been known for several decades (14).
Impaired exercise capacity
Of the participants, 12% were not able to
attain a workload of at least 5 METs, with
58% of the abnormal tests due to im-
paired exercise capacity. Of those who
did not achieve at least 5 METs, 73.6%
reported a Borg score of at least 19, com-
pared with 83.6% of those who did reach
at least 5 METs (P  0.001). Therefore,
motivationmayhavebeenafactorinpoor
exercise capacity for some participants.
Ribisletal.(15)foundthatamongthe
5,145 randomized Look AHEAD partici-
pants,greaterage,higherBMI,andhigher
A1C predicted lower exercise capacity.
The present analysis, which includes par-
ticipants not randomized and thus may
represent a broader and potentially more
generalizable cross-section of the diabetic
population,alsoaddsanalysisofECGand
blood pressure variables. In contrast to
the report of Ribisl et al., the association
between A1C and impaired exercise ca-
pacity is not present in this larger sample.
Myers et al. (2) showed that in 6,213
men referred for a clinical exercise test,
25.5% failed to achieved a maximal exer-
cise capacity of 5 METs, and those with
diabetes had an age-adjusted relative
mortality risk from any cause of 2.3
(95% CI 1.5–3.5) compared with those
whoachieved8METs.Inourstudy,the
lowerprevalence(12%)ofimpairedexer-
cise capacity may be explained in part by
populationdifferences.Participantsinthe
study of Myers et al. underwent exercise
testing for clinical reasons, which in-
cluded symptomatic CVD or other condi-
tions for which potential participants in
LookAHEADwereexcludedbeforestress
testing.
Thisanalysisshoweddivergentdirec-
tionsofassociationbetweenSBPandDBP
and impaired exercise capacity. These bi-
variate associations persist in regression
models in which SBP and DBP are con-
trolled for each other. Elevated SBP is a
well-recognized risk factor for CVD and
Table 2—Systolic blood pressure response (maximum minus pretest resting) and maximum
METs among risk factor subgroups
SBP
response P
Maximum
METs P
Sex
Female 55.1  23.5 0.001 6.7  1.9 0.001
Male 58.9  23.6 7.9  2.2
Age (years)
45 to 55 58.1  22.4 0.001 7.9  2.1 0.001
55 to 65 57.6  23.9 7.3  2.1
65 to 76 52.6  23.6 6.4  1.9
Ethnicity
Latino 54.2  22.6 0.003 7.9  2.1 0.001
Not Latino 57.0  23.7 7.1  2.1
Race
African American 59.8  24.2 0.001 6.7  2.0 0.001
American Indian 43.9  18.8 7.0  2.1
White 56.9  23.6 7.2  2.1
Other/multiracial/unknown 56.9  22.8 8.1  2.2
Use of blood pressure medications
Yes 55.9  23.8 0.002 7.0  2.0 0.001
No 57.9  23.2 7.6  2.3
SBP (mmHg)
120 56.0  22.7 0.01 7.5  2.1 0.001
120–129 58.3  23.5 7.3  2.1
130–139 57.3  24.0 7.1  2.1
140–149 55.6  23.6 7.0  2.1
150–159 55.1  25.2 6.8  2.0
DBP (mmHg)
70 55.3  24.1 0.001 6.9  2.0 0.001
70–84 57.5  23.1 7.4  2.1
85 60.0  23.2 7.8  2.2
Years with diabetes
5 57.8  22.8 0.001 7.4  2.1 0.001
5–9 57.3  23.7 7.2  2.1
10 54.0  24.5 6.8  2.1
CVD history
Yes 50.9  24.2 0.001 6.7  2.0 0.001
No 57.5  23.4 7.3  2.1
BMI (kg/m
2)
25 to 30 57.2  22.9 0.001 8.4  2.4 0.001
30 to 35 57.6  23.1 7.8  2.0
35 to 40 57.5  23.4 6.9  1.8
40 53.8  24.8 5.9  1.5
Insulin use
Yes 54.4  24.9 0.002 6.6  2.0 0.001
No 57.0  23.3 7.3  2.1
A1C (%)
7.0 57.0  22.9 0.39 7.2  2.1 0.35
7.0–8.9 56.3  24.5 7.2  2.1
9.0–10.9 55.8  23.9 7.2  2.0
Data are means  SD. No covariate adjustments have been made.
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cise endurance (16). Sufﬁciently elevated
DBP is also a diagnostic criterion for hy-
pertension and is associated with adverse
CVD events (17) and ischemia (4). How-
ever, in older populations, lower DBP is
associated with CVD (18) and is believed
to result from decreased compliance of
the aorta and its large branches due to
atherosclerotic disease (19). Wider pulse
pressure has been shown to be a strong
predictor of CVD events in older individ-
uals with type 2 diabetes (20). Some
younger Look AHEAD participants may
be expected to have less central athero-
sclerotic burden and, hence, better arte-
rial compliance, on the basis of age alone.
However, all participants had type 2 dia-
betes. The clear association of lower DBP
with abnormal GXTs in this population
suggests that decreased arterial compli-
ance may originate at an earlier age in in-
dividuals with diabetes.
ECG changes
ST segment depression of at least 1.0 mm
is a recognized threshold for an abnormal
ECG response to exercise. This deﬁnition
provides a sensitivity of 45% and a spec-
iﬁcity of 85% for coronary artery disease
diagnosed by angiography (21). Factors
associated with an increased risk of ST
segment depression and ventricular ar-
rhythmia included greater age and lower
BMI. Greater age is a known CVD risk
factor. The association of lower BMI with
ECG changes may be explained by the
increased rate of impaired exercise capac-
ity with higher BMI. Those with a lower
BMI exercised to a higher level (Table 2),
creatingagreatercardiacstress,whichin-
creased the chance of detecting ST seg-
ment changes or arrhythmias.
Angina
Therecentacknowledgmentthatdiabetes
impartsriskofCVDeventsequivalenttoa
known history of CVD (22) makes our
observed rate of angina seem low (1.1%)
for a cohort of individuals with diabetes
aged 45 years. However, before the
GXT, we excluded potential participants
who reported recent angina. The ex-
pected rate of angina in this population is
unknown. Nevertheless, our data show
that even in asymptomatic overweight or
obeseadultswithdiabeteswhohavebeen
carefully screened for cardiovascular
symptoms, angina still occurs with maxi-
mal stress testing, albeit at a rate of 1.1%.
Hemodynamic response
Abnormal heart rate recovery occurred in
5.0% of participants undergoing stress
testing. Many of the predictors of abnor-
mal heart rate recovery we found are
known risk factors for CVD (22). Abnor-
mal heart rate recovery was associated
withhigherBMI.Asdiscussed,thosewith
lower BMI exercised to higher MET levels
than those with higher BMI. However,
those with higher BMI routinely demon-
strate higher workloads for more routine
tasks. This higher inherent workload
leads to a higher catecholamine state,
which causes less difference between
baselineandpeakexerciseheartrateanda
slower heart rate recovery after exercise.
In fact, our data conﬁrm out this conclu-
sion. Higher BMI was associated with a
higher resting and ﬁrst-stage exercise
heart rate and a smaller increase in heart
rate from resting to peak exercise (P 
0.001 in each case, data not shown).
Others have proposed that either an
exaggerated (23) or a low (7,24) SBP re-
sponse may reﬂect underlying cardiovas-
cular abnormalities. The cross-sectional
datapresentedheredonotsettletheques-
tion of whether a larger or smaller SBP
response to exercise increases CVD risk.
However, because greater age was associ-
ated with every category of established
abnormality that we examined and
greater age was associated with lower SBP
response, it is conceivable that a lower
SBP response is associated with higher
risk of adverse CVD outcomes.
Implications of results on future
Look AHEAD study outcomes
LookAHEADGXTeligibilitycriteriawere
adopted for participant safety, given that
unsupervisedexercisetrainingwaspartof
the study intervention. These tests elimi-
nated 638 potential participants: 11.1%
of those reaching the ﬁnal stage of screen-
ing and 49% of those who had abnormal
GXT results. These criteria may reduce
the rate of the trial’s primary end point
and the generalizability of the ﬁndings.
Limitations
For the ﬁrst year of testing, data forms
includedtextﬁeldsfor“signiﬁcantSTseg-
ment changes” and angina; however,
these responses were not required. This
approach was changed thereafter to re-
quire physicians to indicate the degree of
ST depression. Independent reviews by
an experienced exercise physiologist and
a clinician experienced in GXT were con-
ducted for all tests that included at least
1.0 mm of ST depression and the 405 in-
stanceswhenphysiciansnotedSTdepres-
sion but did not quantify it. The 180
instances for which these two reviewers
disagreed were resolved by a cardiologist
independent of Look AHEAD, whose de-
cision was ﬁnal. We did not have sufﬁ-
cient data to comment on ST segment
slope. Full data were not available for the
638 participants who were deemed ineli-
gible for randomization into Look
AHEAD by physicians who supervised
their GXTs, but whose results are in-
cluded in this analysis, which may have
led to an underestimation of abnormality
rates.
Because the present analysis is con-
cerned with baseline data in Look
AHEAD,follow-upoutcomedataonthe
participants are not available for this re-
port. Those with clinically signiﬁcant
abnormalities were referred to their
physicians.
Some clinicians may argue that our
deﬁnition of abnormal GXT results may
more accurately be termed predictors of
CVD events or CVD mortality. Whether
heart rate recovery and maximal achieved
workload should be used to deﬁne ab-
normality or simply be included among
a list of risk criteria is certainly open for
debate; however, for simplicity, we in-
cluded these factors in what we termed
abnormal.
Summary
Among a large cohort of overweight and
obese individuals with type 2 diabetes,
22.5%hadabnormalstresstestsbyECG,
angina, heart rate recovery, or exercise
capacity criteria despite thorough pre-
test screening. Diminished exercise ca-
pacity is the most common abnormality
in this cohort, occurring at nearly twice
the rate of any other abnormality. The
most consistent risk factor for any type of
abnormality is older age, which is even a
more consistent risk factor than duration
of diabetes or history of CVD. These re-
sults support heightened vigilance for
CVDinolderpatientswithdiabetes.Con-
tinued follow-up in these individuals as
part of the Look AHEAD study will deter-
mine whether any of these abnormalities
during exercise testing are accurate pre-
dictors of subsequent cardiovascular
events.
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